NIKE, Inc. $NKE Stock: Candriam S.C.A. Grows Stake

Key Points

• Candriam S.C.A. increased its NIKE stake by 509.4% in the third quarter, adding 606,441 shares to reach 725,483 shares valued at about $25.8 million. Other major investors also expanded holdings, and institutions own 64.25% of the stock.
• NIKE beat quarterly earnings estimates with EPS of $0.48 versus $0.43 expected, but revenue fell 4.3% year over year to $11.21 billion and missed forecasts. The company set FY2027 EPS guidance of $1.15–$1.35.
• Analyst sentiment remains cautious: MarketBeat reports a consensus “Reduce” rating and a $40.91 average price target, while ongoing concerns include weak China sales, shrinking Jordan and Dunk demand, and pressure on the recovery.

Candriam S.C.A. lifted its position in shares of NIKE, Inc. (NYSE:NKE - Free Report) by 509.4% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 725,483 shares of the footwear maker's stock after purchasing an additional 606,441 shares during the quarter. Candriam S.C.A.'s holdings in NIKE were worth $25,776,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of NKE. Flossbach Von Storch SE acquired a new position in NIKE during the second quarter worth $488,714,000. State Street Corp lifted its stake in shares of NIKE by 6.8% in the second quarter. State Street Corp now owns 63,598,789 shares of the footwear maker's stock valued at $2,636,104,000 after buying an additional 4,052,428 shares in the last quarter. Confluence Investment Management LLC grew its holdings in shares of NIKE by 873.8% during the third quarter. Confluence Investment Management LLC now owns 2,720,616 shares of the footwear maker's stock valued at $96,310,000 after buying an additional 2,441,233 shares during the last quarter. Equity Investment Corp acquired a new position in shares of NIKE during the second quarter valued at about $99,531,000. Finally, Amundi grew its holdings in shares of NIKE by 59.4% during the second quarter. Amundi now owns 6,460,398 shares of the footwear maker's stock valued at $265,199,000 after buying an additional 2,406,609 shares during the last quarter. 64.25% of the stock is currently owned by institutional investors.

Key Headlines Impacting NIKE

Here are the key news stories impacting NIKE this week:

• Positive Sentiment: NIKE shares gained 13.9% over the past month, with performance categories and North America showing traction. However, persistent China weakness and earnings pressure make the durability of the rebound uncertain. Read article
• Neutral Sentiment: RBC expects NIKE’s five-year financial targets to be broadly in line with consensus, suggesting its Capital Markets Day may clarify strategy without providing a major near-term catalyst for the stock. Read article
• Negative Sentiment: Analyst caution is weighing on sentiment: Truist downgraded NIKE to “sell” with a $29 target, while UBS maintained “neutral” and a $34 target, warning the recovery may lag valuation expectations. RBC also cut its target to $39 and kept a sector-perform rating. Read article
• Negative Sentiment: Reports point to shrinking Jordan and Dunk sales, with the CEO acknowledging a prior blind spot. A pullback in Jordan sneakers could also create an opening for competitors. Read article
• Negative Sentiment: NIKE’s fiscal 2027 outlook highlights potential sales and earnings pressure; planned $2.5 billion in cost savings could help longer term but may not offset near-term revenue risks. China remains a key concern, with sales there down 25% year over year in the latest reported quarter. Read article

NIKE Stock Performance

NYSE NKE opened at $38.61 on Monday. The company has a fifty day moving average price of $36.91 and a 200-day moving average price of $45.63. The firm has a market cap of $57.35 billion, a price-to-earnings ratio of 18.56, a PEG ratio of 4.51 and a beta of 1.01. The company has a debt-to-equity ratio of 0.39, a current ratio of 2.07 and a quick ratio of 1.39. NIKE, Inc. has a 1 year low of $31.97 and a 1 year high of $69.14.

NIKE (NYSE:NKE - Get Free Report) last released its quarterly earnings results on Thursday, October 1st. The footwear maker reported $0.48 earnings per share for the quarter, beating analysts' consensus estimates of $0.43 by $0.05. NIKE had a net margin of 6.74% and a return on equity of 15.94%. The company had revenue of $11.21 billion for the quarter, compared to analyst estimates of $11.32 billion. During the same period last year, the firm earned $0.49 earnings per share. The firm's revenue was down 4.3% on a year-over-year basis. NIKE has set its FY 2027 guidance at 1.150-1.350 EPS. As a group, equities research analysts predict that NIKE, Inc. will post 1.22 EPS for the current fiscal year.

Insider Transactions at NIKE

In other news, EVP Philip McCartney sold 2,559 shares of the business's stock in a transaction that occurred on Wednesday, September 9th. The stock was sold at an average price of $37.59, for a total value of $96,192.81. Following the transaction, the executive vice president owned 78,121 shares in the company, valued at $2,936,568.39. The trade was a 3.17% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Venkatesh Alagirisamy sold 3,671 shares of the business's stock in a transaction that occurred on Wednesday, September 9th. The stock was sold at an average price of $37.59, for a total value of $137,992.89. Following the completion of the transaction, the chief operating officer owned 104,862 shares in the company, valued at $3,941,762.58. The trade was a 3.38% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 1.10% of the company's stock.

Wall Street Analyst Weigh In

NKE has been the subject of several recent research reports. Morgan Stanley set a $27.00 target price on shares of NIKE and gave the stock an "underweight" rating in a research report on Friday, October 2nd. BMO Capital Markets reaffirmed an "underperform" rating on shares of NIKE in a research report on Thursday, October 22nd. Bank of America reiterated an "underperform" rating and set a $24.00 price target (down from $30.00) on shares of NIKE in a research note on Friday, October 2nd. Benchmark upgraded NIKE to a "hold" rating in a research note on Tuesday, September 22nd. Finally, Citigroup decreased their price objective on NIKE from $39.00 to $32.00 and set a "neutral" rating for the company in a report on Friday, October 2nd. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, twenty have given a Hold rating and twelve have assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Reduce" and a consensus price target of $40.91.

About NIKE

NIKE, Inc designs, develops, markets and sells athletic footwear, apparel, equipment and accessories for sports and fitness, as well as lifestyle products. Its portfolio includes the Nike and Jordan brands, and it owns Converse, which sells casual footwear, apparel and accessories.

The company sells products worldwide through wholesale partners and its own retail stores and digital platforms. Its offerings serve customers across a range of sports and activities, including running, basketball, soccer and training.

NIKE traces its roots to Blue Ribbon Sports, founded in 1964 by Phil Knight and Bill Bowerman.

Want to see what other hedge funds are holding NKE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for NIKE, Inc. (NYSE:NKE - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.